XORTX Therapeutics Management
Management criteria checks 2/4
XORTX Therapeutics' CEO is Allen Davidoff, appointed in Jan 2018, has a tenure of 6.83 years. total yearly compensation is $321.96K, comprised of 79.2% salary and 20.8% bonuses, including company stock and options. directly owns 2.37% of the company’s shares, worth CA$124.79K. The average tenure of the management team and the board of directors is 2.9 years and 4.1 years respectively.
Key information
Allen Davidoff
Chief executive officer
US$322.0k
Total compensation
CEO salary percentage | 79.2% |
CEO tenure | 6.8yrs |
CEO ownership | 2.4% |
Management average tenure | 2.9yrs |
Board average tenure | 4.1yrs |
Recent management updates
Recent updates
Here's Why We're Watching XORTX Therapeutics' (CVE:XRTX) Cash Burn Situation
Aug 23XORTX Therapeutics (CVE:XRTX) Is In A Strong Position To Grow Its Business
Apr 01We're Interested To See How XORTX Therapeutics (CVE:XRTX) Uses Its Cash Hoard To Grow
Dec 16Companies Like XORTX Therapeutics (CSE:XRX) Can Afford To Invest In Growth
Sep 01CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$737k |
Jun 30 2024 | n/a | n/a | -US$1m |
Mar 31 2024 | n/a | n/a | -US$3m |
Dec 31 2023 | US$322k | US$255k | -US$2m |
Sep 30 2023 | n/a | n/a | -US$7m |
Jun 30 2023 | n/a | n/a | -US$7m |
Mar 31 2023 | n/a | n/a | -US$7m |
Dec 31 2022 | US$321k | US$273k | -US$8m |
Sep 30 2022 | n/a | n/a | US$1m |
Jun 30 2022 | n/a | n/a | -US$3m |
Mar 31 2022 | n/a | n/a | -US$2m |
Jan 01 2022 | n/a | n/a | -US$2m |
Sep 30 2021 | n/a | n/a | -US$9m |
Jun 30 2021 | n/a | n/a | -US$3m |
Mar 31 2021 | n/a | n/a | -US$3m |
Dec 31 2020 | US$204k | US$154k | -US$1m |
Sep 30 2020 | n/a | n/a | -US$767k |
Jun 30 2020 | n/a | n/a | -US$536k |
Mar 31 2020 | n/a | n/a | -US$362k |
Dec 31 2019 | US$161k | US$148k | -US$485k |
Sep 30 2019 | n/a | n/a | -US$444k |
Jun 30 2019 | n/a | n/a | -US$582k |
Mar 31 2019 | n/a | n/a | -US$660k |
Dec 31 2018 | US$194k | US$141k | -US$3m |
Compensation vs Market: Allen's total compensation ($USD321.96K) is above average for companies of similar size in the Canadian market ($USD166.75K).
Compensation vs Earnings: Allen's compensation has increased whilst the company is unprofitable.
CEO
Allen Davidoff (64 yo)
6.8yrs
Tenure
US$321,959
Compensation
Dr. Allen Warren Davidoff, Ph.D. is Founder of XORTX Therapeutics Inc. (formerly known as XORTX Pharma Corp.) and has been its Chief Executive Officer and President since January 9, 2018. Dr. Davidoff serv...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.8yrs | US$321.96k | 2.37% CA$ 124.8k | |
Chief Financial Officer | 1.4yrs | US$57.51k | 0.22% CA$ 11.3k | |
Chief Medical Officer | 3.3yrs | US$173.37k | 0% CA$ 0 | |
Chief Business Officer | 2yrs | US$211.33k | no data | |
Director of Communications | no data | no data | no data | |
Director of Corporate Development | 4.3yrs | no data | no data | |
Consultant of Clinical Operations | 2.5yrs | no data | no data | |
Corporate Secretary | no data | no data | no data |
2.9yrs
Average Tenure
60.5yo
Average Age
Experienced Management: XRTX's management team is considered experienced (2.9 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Founder | 6.8yrs | US$321.96k | 2.37% CA$ 124.8k | |
Independent Director | 6.8yrs | US$8.20k | 0.22% CA$ 11.6k | |
Independent Chair of the Board | 2.4yrs | US$101.11k | 0.30% CA$ 15.7k | |
Member of Clinical Advisory Board | no data | no data | no data | |
Independent Director | 3.5yrs | US$7.87k | 0% CA$ 0 | |
Independent Director | 2.9yrs | US$7.37k | 0% CA$ 0 | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Clinical Advisory Board | 6.1yrs | no data | no data | |
Independent Director | less than a year | no data | 0% CA$ 0 | |
Member of Clinical Advisory Board | 6.1yrs | no data | no data | |
Member of the Clinical Advisory Board | 4.7yrs | no data | no data | |
Member of the Advisory Board | 3.3yrs | no data | no data |
4.1yrs
Average Tenure
68.5yo
Average Age
Experienced Board: XRTX's board of directors are considered experienced (4.1 years average tenure).